Skip to main content

The Globe and Mail

Saskatchewan to cover expensive cystic fibrosis drug Kalydeco

Vertex Pharmaceuticals and the PCPA have settled on a price for Kalydeco. Saskatchewan has agreed to cover the cost of the drug starting Monday.

Katelyn Verstraten

The Saskatchewan government is to begin providing coverage for a cystic fibrosis drug starting next week.

The province says the oral medication Kalydeco will be covered starting Monday.

The drug can be expensive with costs running to $300,000 a year for one patient.

Story continues below advertisement

Drug-maker Vertex Pharmaceuticals reached an agreement with the provincial and territorial governments in June to enable public drug plans to cover the medication's cost.

Negotiations had been going on for more than a year.

It's believed to be the first drug that corrects the faulty mechanism that causes cystic fibrosis in the first place.

The drug only works for a small subset of patients whose disease is caused by a mutation on the specific gene.

Report an error
As of December 20, 2017, we have temporarily removed commenting from our articles. We hope to have this resolved by the end of January 2018. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to If you want to write a letter to the editor, please forward to